U.S., Dec. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07305350) titled 'EFFICACY OF MELATONIN IN MANAGEMENT OF HYPOXIC ISCHEMIC ENCEPHALOPATHY (HIE) IN NEONATES' on Dec. 12.
Brief Summary: To compare the survival rate and improvement in stage of hypoxic ischemic encephalopathy (HIE) at day 7 of treatment in neonates treated with versus without melatonin in addition to standard supportive therapy.
Study Start Date: Dec. 10
Study Type: INTERVENTIONAL
Condition:
Hypoxic Ischaemic Encephalopathy (HIE)
Intervention:
DRUG: Melatonin
55 neonates will be assigned group A in which newborns will be given single 10mg dose of melatonin through nasogastric tube in addition to standard supportive therapy.
COM...